检索

期
标题
作者
卷 26, 编号 12 (2019)
A clinical case of using ribociclib with an aromatase inhibitor in metastatic hormone-receptor-positive HER2-negative breast cancer with a rare location of metastasis
Fateeva A., Zyuzyukina A., Zukov R.
PDF
(Rus)
编号 17 (2017)
Palbociclib - new possibilities of therapy of hormon-positive HER2-negative breast cancer
Zhukova L., Chichikov E., Gordeeva O., Filonenko D.
PDF
(Rus)
卷 31, 编号 7 (2024)
Analysis of pharmacotherapy in patients with HR+HER2- metastatic breast cancer with PIK3CA mutations in real clinical practice
Fateeva A., Eliseeva E., Apanasevich V., Zaemskaya A.
PDF
(Rus)
卷 31, 编号 6 (2024)
Assessing the risk of recurrence of luminal HER2-negative breast cancer and the possibility of intensifying adjuvant hormonal therapy to reduce the risk of progression
Gordeeva O.
PDF
(Rus)
卷 28, 编号 7 (2021)
Abemacyclib is a unique representative of the class of CDK4/6 inhibitors in the treatment of HR+/HER2- metastatic breast cancer
Grechukhina K., Vorontsova K., Kuko T., Prosvirnov A., Ganshina I., Lubennikova E., Kolyadina I., Zhukova L.
PDF
(Rus)
编号 12 (2018)
Ways to improve efficiency of endocrino-therapy of breast cancer: new targeted cells, new therapeutic opportunities
Semiglazov V., Semiglazov V., Nikolaev K., Dashyan G., Komyakhov A., Paltuev R., Appolonova V., Donskikh R., Tseluyko A., Semiglazova T., Zhiltsova E., Krivorotko P.
PDF
(Rus)
编号 7 (2018)
CYCLIN-DEPENDENT KINASE INHIBITORS - NEW THERAPEUTIC OPTION FOR PATIENTS WITH HORMONE-DEPENDENT HER2-NEGATIVE BREAST CANCER: CLINICAL EXPERIENCE
Sakaev D., Iskhakova A., Kunafina R.
PDF
(Rus)
1 - 7 的 7 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语